Bala, Juanito E.

HRN: 20-71-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/07/2023
10/14/2023
IV
2.25g
Q8hrs
Catheter Associated Uti
Waiting Final Action 
10/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/07/2023
10/08/2023
IV
4.5g
Loading Dose
Catheter Associated UTI
Waiting Final Action 
10/07/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/07/2023
10/14/2023
IV
2.25g
Q6h
Catheter Associated UTI
Waiting Final Action 
10/16/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/16/2023
10/22/2023
IV
4.5
Q6
Pneumonia
Waiting Final Action 
10/17/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2023
10/23/2023
IV
600mg
Q8
Non Healing Infected Wound
Waiting Final Action 
10/20/2023
LEVOFLOXACIN 500MG (TAB)
10/20/2023
10/27/2023
VIA NGT
500mg/tab Half Tab
OD
Catheter Associated UTI
Waiting Final Action 
10/20/2023
MUPIROCIN 2%, 15G (TUBE)
10/20/2023
10/27/2023
TOPICAL
Sufficient Amount
BID
Infected Wound
Waiting Final Action 
10/25/2023
MUPIROCIN 2%, 15G (TUBE)
10/25/2023
10/31/2023
TOPICAL
Apply Thinly
BID
Wound On Penis
Waiting Final Action 
11/06/2023
CEFTRIAXONE 1G (VIAL)
11/06/2023
11/13/2023
IV
2 Grams
OD
CAP-MR
Waiting Final Action 
11/06/2023
MUPIROCIN 2%, 15G (TUBE)
11/06/2023
11/13/2023
TOPICAL
2%
OD
Decibitus Ulcer
Waiting Final Action 
11/09/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/09/2023
11/15/2023
IV
4.5g
Q8
CAP-MR
Waiting Final Action 
11/09/2023
CLARITHROMYCIN 500MG (CAP)
11/09/2023
11/15/2023
NGT
500mg
BID
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: